Quantum stereodynamic control of the Ne + H2+ ( <i>v</i> 0 = 0–2, <i>j</i> 0 = 1) proton transfer reaction

Y Ye Mao (School of Physics and Electronic Technology, Liaoning Normal University , Dalian 116029,) Z Zijiang Yang (Institute of Molecular Medicine (IMM), Department of Nephrology, Molecular Cell Laboratory for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Uremia Diagnosis and Treatment Center, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Medicine, School of Chemistry and Chemical Engineering)

Abstract

This study explores the quantum stereodynamic control of proton transfer in the Ne + H2+ (v0 = 0–2, j0 = 1) → NeH+ + H reaction using the time-dependent wave packet approach. The calculated isotropic integral cross sections for v0 = 1 and 2 are in reasonable agreement with the latest experimental results. Regarding the stereodynamic effects, the parallel configuration enhances reactivity, while the perpendicular configuration suppresses it in the endothermic reactions (v0 = 0–1). For the exothermic v0 = 2 case, the parallel configuration exhibits an inhibitory effect at low collision energies but, together with the perpendicular configuration, enhances the reactivity at higher energies. Moreover, the parallel alignment favors energy transfer into product translation, enhancing forward scattering. In contrast, the perpendicular alignment drives energy into rotation, resulting in increased sideways and backward scattering. These results are expected to shed light on future experimental and theoretical efforts aimed at understanding orientation-controlled proton transfer in rare-gas atom–molecule ion reactions.

Article Details

Volume / Issue Vol. 164, Issue 2
Published January 14, 2026
ISSN 0021-9606
Publisher American Institute of Physics

Journal Info

The Journal of Chemical Physics

American Institute of Physics

ISSN: 0021-9606 Physical Sciences

Authors (2)

Y

Ye Mao

School of Physics and Electronic Technology, Liaoning Normal University , Dalian 116029,

Z

Zijiang Yang

Institute of Molecular Medicine (IMM), Department of Nephrology, Molecular Cell Laboratory for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Uremia Diagnosis and Treatment Center, State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Medicine, School of Chemistry and Chemical Engineering